Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Bio-Bridge Science is a biotechnology firm focused on the development of vaccines with broad therapeutic and preventive applications. Through its wholly owned subsidiary in Beijing, Bio-Bridge is developing a promising new HIV Vaccine, that is expected to enter clinical trials in China in the very near future. The vaccine, based on exclusive technology co-developed by CEO Liang Qiao, an associate professor at Loyola University Chicago’s Stritch School of Medicine, targets infection in mucosal tissues, the first type of tissue attacked by ( www.bio-bridge-science.com )
Bio-Bridge Science , Inc.
1211 West 22Nd Street Suite 615
Oak Brook, Illinois 60523
USA
Tel: (630) 928-0869
Fax: (630) 203-6088